This has opened the way to the use of glucagon mini-doses that have recently been administered at doses of 100–150 μg instead of 1 mg, both in adults and in infants, to prevent or to treat mild hypoglycemia [49,50,51]. This evidence concerns the gene GCG and Hypoglycemia.